PAUL A FRIEDMAN
CIK 1236927 · Chief Executive Officer · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$447.98M
Companies
10
Total Filings
118
Lifetime Open-Market Net
-$322.93M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRLD | Director | 500,098 | $4.49 | $2.25M | $0 | 7 | 2026-06-10 |
| MDGL | Director | 865,744 | $480.77 | $416.22M | -$146.42M | 24 | 2026-01-13 |
| INCY | Director | 271,813 | $108.53 | $29.50M | -$175.53M | 41 | 2020-05-28 |
| Dare Bioscience, Inc. (CERU) Delisted | Director | 18,819 | — | — | $0 | 6 | 2017-04-05 |
| VSTM | Director | 3,000 | $4.10 | $12.3K | $24.9K | 3 | 2016-06-16 |
| MADRIGAL PHARMACEUTICALS, INC. (SNTA) Delisted | Director | 5,681 | — | — | $0 | 3 | 2015-07-06 |
| AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Director | 5,000 | — | — | -$1.00M | 23 | 2015-01-30 |
| Durata Therapeutics, Inc. (DRTX) Delisted | Director | — | — | — | $0 | 1 | 2013-05-20 |
| Sirtris Pharmaceuticals, Inc. (SIRT) Delisted | Director | — | — | — | $0 | 1 | 2008-04-18 |
| BAUSCH & LOMB INC (BOL) Delisted | Director | 2,286 | — | — | $0 | 1 | 2007-09-25 |
Recent Filings · Page 9 of 12
118 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-02-12 | INCY | Grant (A) | — | $0 | EDGAR |
| 2013-01-03 | AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Mixed | −2,050 | $7.5K | EDGAR |
| 2012-12-20 | INCY | Tax (F) | −16,725 | -$270.1K | EDGAR |
| 2012-10-02 | AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Grant (A) | +306 | $7.5K | EDGAR |
| 2012-07-12 | INCY | Exer (M) | +25,186 | $189.4K | EDGAR |
| 2012-07-03 | AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Grant (A) | +231 | $6.2K | EDGAR |
| 2012-06-22 | AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Grant (A) | +5,000 | $0 | EDGAR |
| 2012-05-08 | INCY | Mixed | — | -$3.73M | EDGAR |
| 2012-04-03 | AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Grant (A) | +336 | $6.2K | EDGAR |
| 2012-01-23 | INCY | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.